Bio-Techne outlines 100 basis points margin expansion for FY26 following Exosome Diagnostics divestiture Bio-Techne outlines 100 basis points margin expansion for FY26 following Exosome Diagnostics divestiture Post ContenttechRead More You might also be interested in reading UAE Leads World in Crypto Obsession, Study Finds. August 6, 2025 In Mainstream ← Previous post Next post →